September 11, 2011

Sunday, September 11, 2011
Remembering9-11


Although most of us remember 9/11 through media coverage, a vast amount of victims and heroes now remain permanently scarred from witnessing the tragedy first-hand. Many are still physically suffering from their exposure to a mix of fibers, metals, concrete, noxious chemicals and gases. Yet many others are suffering mentally from their experiences on that day and the days following.
“Officially, as many as 10,000 firefighters, police officers and civilians who were at the disaster site here have been diagnosed with post traumatic stress disorder (PTSD). Other figures suggest more than 60,000 of the 409,000 who were at Ground Zero have shown elements of PTSD.”
In the past 10 years, there has been more research and attention given to the very real PTSD and the stigma of mental illness and seeking treatment has also diminished somewhat.

So today, many of us are not only remembering where we were or what we were doing on that day, but those that perished, lost their lives trying to save lives and those still affected.

For more on PTSD, visit this past post: http://www.mentalhealthblog.com/2008/09/ptsd-victims-of-911.html

Our faded memories of 9-11

© www.mentalhealthblog.com

September 4, 2011

Sunday, September 04, 2011
New research suggests that infants can be trained to improve their concentration skills much earlier than once thought, which, unlike adults, can lead to improvements on unrelated tasks. Such abilities could lead to greater academic success, especially for those infants that may not be expected to thrive.
"Research suggests that differences in attentional control abilities emerge early in development and that children with better attentional control subsequently learn better in academic settings," said Sam Wass of the Centre for Brain and Cognitive Development at Birkbeck, University of London.
In other words, infants that can more readily concentrate on a specific object while ignoring other distractions are better equipped to learn. To test this theory, researchers observed 42 eleven-month-old infants on 5 occasions over 15 days. The cognitive abilities of each child were tested at the beginning and end of the 15 day period. Half of the babies watched TV, while the other half explored images on a computer screen. The latter half were tested to see how long they could watch a butterfly that flew only as long as they kept their eyes on it, meanwhile other distracting elements appeared on the screen.

Results showed that, “trained infants rapidly improved their ability to focus their attention for longer periods and to shift their attention from one point to another. They also showed improvements in their ability to spot patterns and small but significant changes in their spontaneous looking behavior while playing with toys”.

Consequently, the ability to stay focused on a task or to quickly shift attention can facilitate learning and social interactions, which can significantly impact abilities later in life.

Although the plasticity of the infant brain might allow training to occur at an earlier age, it remains a mystery whether infants might lose their novel skills just as quickly as they were learned.

Infants Trained to Concentrate Show Added Benefits

© www.mentalhealthblog.com

August 7, 2011

Sunday, August 07, 2011
According to Larry D. Rosen, PhD, professor of psychology at California State University, Dominguez Hills, the effects of social media are becoming more and more visible.

Some of their findings suggest that the more time spent on Facebook is related to a greater tendency toward narcissistic behaviors among teenagers. Also, it has been discovered that young adults that spend excessive amounts of time on Facebook show more signs of other psychological disorders, including antisocial behaviors, mania and aggressive tendencies.

Additionally, studies have revealed that excessive daily use of social media can negatively affect the health of children, preteens and teenagers alike as they are more prone to anxiety, depression and other psychological disorders as well as more susceptible to future general health problems.

Furthermore, it is clear that school grades will suffer when spending too much time on Facebook as valuable study time is lost. “Studies found that middle school, high school and college students who checked Facebook at least once during a 15-minute study period achieved lower grades.”

Besides, some studies suggest that so-called teenage “hyper-social networkers” are more likely to engage in risky behaviors, such as smoking, drinking, drug use, fighting and promiscuity.

Consequently, Rosen claims that parents who secretly monitor their child’s social media usage are wasting their time. Instead he suggests that active, but overt, monitoring and open communication about appropriate usage is the key so that when questions or issues arise such as bullying, a child will feel comfortable communicating with their parents. This active role could prevent serious consequences such as depression, anxiety or even suicide. It is also important for parents to stay abreast with online trends and the latest technologies, websites and applications.

On the other hand, research has shown that, despite the numerous negative effects, Facebook can help young adults to express their virtual empathy and facilitate socialization among introverted teens. Also, “social networking can provide tools for teaching in compelling ways that engage young students.”

It seems, like most things in life, everything in moderation is best.

Social Networking's Good and Bad Impacts On Kids
Texting and Social Websites Associated With Risky Behaviors Among Teens

© www.mentalhealthblog.com

July 23, 2011

Saturday, July 23, 2011
In recent news, scientists have uncovered the molecular pathway involved in the onset of schizophrenia as well as a potential new treatment for the illness. By observing the effects of a cancer drug called MS-275 in mice, researchers discovered that symptoms of schizophrenia were successfully alleviated.

Schizophrenia is a mental disorder characterized by disintegration of thought processes and emotional responsiveness. It is most commonly manifested as auditory hallucinations, paranoid or bizarre delusions, or disorganized speech and thinking. The onset of symptoms typically occurs in young adulthood. Schizophrenia is accompanied by significant social or occupational dysfunction.

Additionally, the disease is said to be caused by a combination of genetic and environmental factors. Those with a diagnosis of schizophrenia have changes in both brain structure and chemistry. Studies using neuropsychological tests and brain imaging technologies such as fMRI and PET to examine functional differences in brain activity have shown that differences seem to most commonly occur in the frontal lobes, hippocampus and temporal lobes.

The greatest risk for developing schizophrenia is having a first-degree relative with the disease. Environmental factors associated with the development of schizophrenia include the living environment, drug use and prenatal stressors. Factors such as hypoxia and infection, or stress and malnutrition in the mother during fetal development, may result in a slight increase in the risk of schizophrenia later in life. A number of drugs have been associated with the development of schizophrenia including cannabis, cocaine and amphetamines.
“According to the World Health Organization, 90% of people with untreated schizophrenia are in developing countries. Current treatments for schizophrenia include both psychological treatments such as psychotherapy, counselling or cognitive behaviour therapy and/or medication. However, many of the antipsychotic drugs or major tranquillisers used to treat or manage the illness have very bad side-effects.”
Schizophrenia is said to affect about 24 million people worldwide.

Medications prescribed to treat schizophrenia include:
    • Chlorpromazine (Thorazine)
    • Haloperidol (Haldol)
    • Perphenazine (generic only)
    • Fluphenazine (generic only)
    • clozapine (Clozaril)
    • Risperidone (Risperdal)
    • Olanzapine (Zyprexa)
    • Quetiapine (Seroquel)
    • Ziprasidone (Geodon)
    • Aripiprazole (Abilify)
    • Aliperidone (Invega)
Typical side effects include:
    • Drowsiness
    • Dizziness when changing positions
    • Blurred vision
    • Rapid heartbeat
    • Sensitivity to the sun
    • Skin rashes
    • Menstrual problems for women
    • Rigidity
    • Persistent muscle spasms
    • Tremors
    • Restlessness
Professor Peter Giese at King's College London discovered that individuals with schizophrenia had a reduction in the enzyme activator called p35. By manipulating the level of this enzyme in mice, the researchers were able to mirror typical cognitive impairments found in those with schizophrenia. Consequently, human post-mortem brains revealed that schizophrenic patients had approximately 50% less p35 in their brains.

That being said, the brain requires, among other things, the activation of a protein call Cdk5 to assist in proper development and this protein can only be activated in the presence of the p35 enzyme.

Therefore, by manipulating the level of p35 enzyme in mice, researchers noted that “the mice showed a reduction in synaptic proteins -- important in maintaining neural connections -- and displayed symptoms associated with schizophrenia, including learning impairments and inability to react to sensory stimuli.”

Subsequently, Professor Giese and his research team noticed that the reduction of the p35 enzyme altered molecules in the brain that are targeted by the cancer drug MS-275. To their delight, the molecular changes were corrected and the schizophrenic symptoms were alleviated by this drug.

With any luck, more research will prove that this drug is more beneficial than current medications with intolerable side-effects.

Cancer Drugs May Help Treatment of Schizophrenia
Schizophrenia
Mental Health Medications

© www.mentalhealthblog.com

July 3, 2011

Sunday, July 03, 2011
Researchers of the CRASH-2 Intracranial Bleeding Study have uncovered the possibility that tranexamic acid may be able to prevent people from dying of head injuries. This hypothesis was derived from the examination of 270 adult trauma patients with traumatic brain injury and with, or at risk of, significant extracranial bleeding within 8 hours of injury. Results of the study were persuasive enough that a CRASH-3 study is needed to test the reliability of this drug among patients with head trauma.

Tranexamic acid, otherwise known as Lysteda or Cyklokapron in the U.S., is often prescribed for excessive bleeding. “It is an antifibrinolytic that competitively inhibits the activation of plasminogen to plasmin, a molecule responsible for the degradation of fibrin. Fibrin is the basic framework for the formation of a blood clot in hemostasis.” In addition to its value for treating trauma patients, it has been used to treat cases of excessive menstrual bleeding, to reduce blood loss during orthopedic surgery, as a mouthwash following dental surgery, as well as in obstetrics, cardiac surgery, hemophilia and hereditary angioedema.

If approved, tranexamic acid could be used immediately following trauma when bleeding typically progresses and causes more and more brain damage by reducing the breakdown of blood clots and decreasing the amount of bleeding into the brain thereby preventing brain damage and even death.
“Although the results are not definitive they provide hope about the potential effectiveness of this simple drug for head injury patients. If such an inexpensive and widely practicable treatment were found to improve patient outcomes after head injury this would have major implications for clinical care” Said Dr Pablo Perel.
Hopefully, CRASH-3 trials will unveil conclusive results so that such a simple treatment could be incorporated immediately following traumatic brain injuries to increase survival rates and reduce disability, not to mention avoiding extensive and challenging rehabilitation.

Potential of Simple Injection On Patients With Head Injury
Tranexamic acid

© www.mentalhealthblog.com

May 31, 2011

Tuesday, May 31, 2011
According to researchers of the Centre for Studies on Human Stress of Louis-H. Lafontaine Hospital at the University of Montreal, our brain loses its ability to associate negative emotions with painful memories while using the drug metyrapone.
“‘Metyrapone is a drug that significantly decreases the levels of cortisol, a stress hormone that is involved in memory recall,’ explained lead author Marie-France Marin. Manipulating cortisol close to the time of forming new memories can decrease the negative emotions that may be associated with them. "The results show that when we decrease stress hormone levels at the time of recall of a negative event, we can impair the memory for this negative event with a long-lasting effect," said Dr. Sonia Lupien, who directed the research.”
Researchers taught 33 men a story that consisted of neutral and negative events. They separated the men into different groups and observed them 3 days later. A third of the participants received a single dose of metyrapone, another third received a double dose and the final third received a placebo. Researchers asked the participants to recall the story while under the influence of the drug they were given. Their memory of the story was evaluated while using the drug and again 4 days later when the drug was no longer circulating in their bloodstream.
“‘We found that the men in the group who received two doses of metyrapone were impaired when retrieving the negative events of the story, while they showed no impairment recalling the neutral parts of the story,’ Marin explained. ‘We were surprised that the decreased memory of negative information was still present once cortisol levels had returned to normal.’”
Consequently, such research could be very useful in treating mental illness. Not only could this drug be successful in treating post-traumatic stress disorder (PTSD), but it could help many people with mental health issues resulting from traumatic experiences.

Unfortunately, metyrapone is no longer commercially produced; however research on the impact of certain compounds on cortisol levels can only lead to a better understanding of the way in which our brain processes negative emotions and memories. Additionally, this type of research may lead to the discovery of other medications that are currently available or potentially more successful in erasing our bad memories.

On the other hand, use of such a drug could lead to abuse as many of us could certainly pinpoint at least one painful memory that we would be willing to let go. Also, despite those whose lives have been seriously disrupted from past trauma, it is our experiences, both positive and negative, that molds us into the person we have become. Therefore, erasing our experience of negative emotions from certain memories may be toying with our personality and possibly creating havoc in our society.

Drug May Help Overwrite Bad Memories

© www.mentalhealthblog.com

May 28, 2011

Saturday, May 28, 2011
A great deal of research boasts about the benefits of omega 3 fatty acids found in fish oil supplements. Now researchers at the Indiana University School of Medicine have found that it could also be beneficial in treating alcoholism and psychiatric disorders.
“In a multi-year study, researchers showed conclusive behavioral and molecular benefits for omega 3 fatty acid given to mice models of bipolar disorder. The fatty acid DHA, which is one of the main active ingredients in fish oil, "normalized their behavior," according to Alexander B. Niculescu, M.D., Ph.D., associate professor of psychiatry and the lead author of the study reported online in the Nature Publishing Group journal Translational Psychiatry.”
Researchers were able to draw such conclusions by studying the effects of Docosahexaenoic acid (DHA) on mice with characteristic bipolar symptoms including depression and manic episodes when exposed to stress.

Results showed that DHA normalized the behavior of the mice as they showed no signs of depression and experienced no periods of mania when under stress. Furthermore, molecular changes in their brain resulting from DHA correlate with molecular markers found in the blood, suggesting that DHA works similarly to psychiatric medications in the brain. According to Dr. Niculescu, "with these biomarker findings, we can now move forward as a field and do more targeted clinical studies in humans".

In addition, while studying the effects of DHA on the brain, researchers discovered that mice given DHA had less desire for alcohol.
“'These bipolar mice, like some bipolar patients, love alcohol. The mice on DHA drank much less; it curtailed their alcohol abusive behavior,' he said, adding that this is a completely novel finding. To verify this finding, the researchers studied another well-established animal model of alcoholism, the alcohol preferring P rats, and obtained similar results.”
Perhaps fish oil supplements may soon be used to treat bipolar disorder and alcoholism either exclusively or in conjunction with other treatment methods, thereby reducing unpleasant side effects of psychiatric medications while potentially improving overall health.

Fish Oil May Have Positive Effects on Mood, Alcohol Craving, New Study Shows

© www.mentalhealthblog.com

Popular Posts

Dentalget.com is dental equipment supplier, we provide high quality dental instruments, dental handpiece at a discount price. Free shipping worldwide.

Categories

9/11 AADD Abortion Academic Success Acetylcholine ADD Adderall Addiction ADHD Adult Attention Deficit Disorder Adultery Advertising Aggression Aging Agreeableness AIDS Air Pressure Alcohol Alcohol Abuse Alcohol Dependence Alcoholism alpha-CaM kinase II Altitude Alzheimer's Amphetamine Amygdala Amyloid Amyloid Deposition Anesthesia Anger Anterior Cingulate Cortex Anterograde Amnesia Anti-Depressants Anti-Psychotic Anticholinergic Anticonvulsant Antiepileptic Antioxidants Anxiety Anxious-Avoidant Anxious-Preoccupied Apolipoprotein E Army Aromatherapy Asperger Syndrome Assessment Associative Learning Asthma Attachment Theory Attention Attention Deficit Disorder Attention Deficit Hyperactivity Disorder Autism Autism Spectrum Disorder Autonomic Nervous System Average Sleep Requirements B-type Natriuretic Peptide Babies Balance Behavioral Problems Behaviour Behavioural Impairment Behavioural Therapy Benadryl Bipolar Disorder Blood Clot Blood Pressure Blue Light Blue Light Goggles Body Mass Index Bone Marrow Brain Brain Development Brain Imaging Brain Injury Brain Stem Brain Surgery Breast Cancer Buddhism bullying Bupropion Business C-reactive Protein Calories CAMH Canada Canadian Charter of Rights and Freedoms Cancer Carbohydrates Cardiovascular Disease Care Facilities Caregiver cars Cdk5 Cell Phone Central Nervous System Centre for Addiction and Mental Health Cerebellum Cerebral Amyloid Angiopathy Cerebral Cortex Cerebrospinal Fluid Cerebrovascular Accident Cerebrovascular Insult Chat Rooms Chewing Childhood Disabilities Childhood Disintegrative Disorder Childhood Emotional Neglect Children Chitin Chitosan Cholesterol Choline Chromosome Chronic Pain Syndrome Chronic Stress Circadian Rhythm Cirrhosis Citalopram Classical Conditioning Climate Change Clot-Busting Drug Co-morbidity Cocaine Cognition Cognitive Development Cognitive Impairment Colloquially Brain Attack Coma Communication Device Communication Technology Concentration Concerta Concussion Conflict Confusion Conscientiousness Control Group Coordination Correlation Cortisol Counselling Couples CPAP Crack CRASH-2 CRASH-3 Creativity Criminal Code Cyberbullying Cyberpsychology Cyklokapron Daytrana Death Death Toll Decision-Making Declarative Memory Deep Brain Stimulation Delusion Dementia Dentures Depression Destrostat Deviant Behaviour Dexedrine Dextromethorphan Diabetes Diet Dietary Supplements Diphenhydramine Disability discrimination Dismissive-Avoidant Disorganized Attachment Disorganized Speech Disorientation Dizziness Docosahexaenoic Acid (DHA) Double-Blind Dream Drinking Drowsiness Drug Abuse Drug Dependence Drug Use Drugs DSM DSM-5 Dual Diagnosis Early Onset Alzheimer's Economic Crisis Ecstasy Effexor Ego Eicosapentaenoic Acid (EPA) Elderly Electrical Stimulation Electroconvulsive Therapy Electrodes Email Embitterment Embolic Emotion Emotional Neglect Emotional Problems Emotional Well-Being Employee Enrivonment Enzyme Epilepsy Estrogen Ethics Evolution Experimental Group Extracellular Signal-Regulated Kinase (ERK) Extroversion Facebook Facebook Fan Page Facebook Friends Family Family Therapy Fast Food Father Father Absenteeism Fatherhood FDA Fear Fearful-Avoidant FeelingBetterNow Fetus Fibrin Fish Oil fluoxetine fMRI Focalin Focus Food Fraud Friday Gamma Secretase Genetic Disorders Genetics Ginkgo Biloba Glucose Glutamate Receptor God Gout Guest Blogger Hair Pulling Haiti Hallucination Hallucinogenic Halo Effect Harm-Reduction Headache Healthy Eating Hearing Heart Attack Heart Disease Hematopoietic Stem Cells Hepatitis Hepatitis C Herbal Supplements Hereditary Angioedema Heredity Heroin High Blood Pressure Hippocampus Hockey Homelessness Hormone Housing Hox Genes Hoxb8 Cells Human Rights Hydromorphone Hyper-social Networker Hyperactivity Hypothalamus Illness Impulse Control Impulsivity Inattentiveness Infant Infidelity Inflammation Insecure Attachment Insomnia Instant Messaging Insulin Intellectual Development Intellectual Disability Internet Intracranial Bleeding Introversion Introvert Ischemic Stroke KASPAR Ketamine Ketogenic Kleptomania Laptop Latent Inhibition Learning Learning Disability Leukotrienes Limbic System Lithium Liver Locked-In Syndrome Long Term Memory Long-Term Potentiation Longevity Lupus Lysteda Maestro Rechargeable System Major Depression Mania MAOI Marriage MDMA Medication Meditation Melatonin Memory Memory Loss Memory Task Men Mental Health Mental Health Forum Mental Heath Mental Illness Metadate Metyrapone Mice Microglia Mild Cognitive Impairment (MCI) Mild Traumatic Brain Injury Military Mind-Body Mindless Eating Mitochondria MOHLTC Mood Disorder Morphine Mortality Rates MRI MS-275 Multiple Sclerosis Muscle Weakness music therapy Narcissism Natasha Richardson National Sleep Foundation Natural Disaster Nature/Nurture Nausea Necrosis Neglect Nerve Neuro-imaging Neurobiology Neurodegeneration Neurodegenrative Diseases Neurodevelopment Disorders Neurogenesis Neurological Disease Neuromarketing Neuron Neuropathy Neuroticism Neurotransmitter News Nintendo Wii Non-REM Sleep Nose Nurse Ratched Nutrition Obesity Obessive Compulsive Spectrum Disorder (OCD) Offspring Olfactory Gland OM3 Emotional Balance Omega 3 Ontario Ontario Review Board Ontario Works Opioid Oral Health Organic Ottawa Over-activity Over-Medication Ovulation Oxidative Cell Oxygen Oxytocin p35 Pacemaker Pain Pain Killer Pain Management Pancreatic Polypeptide Pancreatitis Paralysis Paranoia Paraskevidekatriaphobia Parenthood Parents Parkinson's Paroxetine Paxil PDD-NOS perception Perfume Peripheral Nervous System Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Pathway personality traits Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) PET Scan Pharmacology Phobias Physical Health Physiological Plasmin Plasminogen Plasticity Platelet-Activating Factor Politics Post-Concussion Assessment and Cognitive Test (ImPACT) Potassium Ion Channel Poverty Pregnancy Pressure Procedural Memory Promiscuity Prozac PsychBoard.com Psychiatric Ward Psychological Psychological Inventories Psychologist Psychology Psychology Forum Psychology of Eating Psychosis PTED PTSD Public Health Pyromania Quadriplegic Rehab Relationships Reliability Religion REM Research Retigabine Retrograde Amnesia Rett Syndrome Risperdal Ritalin road rage Robot Robotics Rodent Research Rosiglitazone Samsung Satiety Scales Schizophrenia School Screening Secure Attachment Sedatives Seizure Self-Affirmation Intervention Self-Confidence Self-Esteem Self-Integrity Self-Worth Semantic Memory Senior Seroquel Serotonin Serzone Sex Sex Therapy Sexual Orientation Sexual Satisfaction Shock Therapy Sideline Concussion Assessment Test (SCAT2) Sleep Sleep Apnea Sleep Disorders Sleep Quality Sleep Stages Smartphone Smoking Snacking Sniffing Technology Social Assistance Social Deficits Social Isolation Social Media Social Network Social Rejection Social Skills Social Worker Socialization Societal Change Soft Palate Soldier Somatic Nervous System Spatial Memory Special K Speech Spinal Cord Spinal Cord Injury Spinal Tap Sports Injury SSRI Statin Stem Cell Stimulant Strattera Stress Stress Hormone Stroke Substance Abuse Sugar Suicide Superstition Support Survey Suspicious Tablet Talk Therapy Tamoxifen Tanorexia Tax Payer Technology Television Telomere Temperature Testosterone Texting Therapy Thorazine Threshold Thrombosis Thrombotic Tinnitus Tissue Plasminogen Activator Topographical Disorientation Tranexamic Acid Trauma Treatment Tremors Trial Tribunal Trichotillomania Type-2 Diabetes Vagus Nerve Validity Ventromedial Prefrontal Cortex Video Games Virtual Reality Vision Visual Attention Vitamin B Vitamins Vitiligo Voice Vyvanse Walnuts Weight Loss Welfare Wellbutrin Wernicke–Korsakoff syndrome Wet Brain White Blood Cells Women Work World Health Organization Zileuton Zyban Zyprexa µ-opiate receptors (MOR)